ArticleMultiple sclerosis journal - experimental, translational and clinical2021

Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy.

Audrey Rico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.